Back to top
more

Adicet Bio (ACET)

(Delayed Data from NSDQ)

$0.67 USD

0.67
271,777

-0.02 (-2.19%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $0.66 -0.01 (-1.58%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks News

Zacks Equity Research

Top Ranked Value Stocks to Buy for February 24th

Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 24th:

    Zacks Equity Research

    Top Ranked Value Stocks to Buy for February 22nd

    Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 22nd:

      Zacks Equity Research

      Top Ranked Value Stocks to Buy for February 21st

      Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 21st:

        Zacks Equity Research

        Top Ranked Value Stocks to Buy for February 16th

        Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 16th:

          Zacks Equity Research

          Top Ranked Value Stocks to Buy for February 14th

          Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 14th:

            Zacks Equity Research

            Aceto (ACET) is Oversold: Can It Recover?

            Aceto Corporation (ACET) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

              Zacks Equity Research

              Top Ranked Value Stocks to Buy for February 9th

              Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 9th:

                Zacks Equity Research

                Top Ranked Value Stocks to Buy for February 7th

                Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 7th:

                  Zacks Equity Research

                  Top Ranked Value Stocks to Buy for February 6th

                  Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 6th:

                    Zacks Equity Research

                    Top Ranked Value Stocks to Buy for February 3rd

                    Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, February 3rd:

                      Zacks Equity Research

                      Falling Earnings Estimates Signal Weakness Ahead for Eagle Pharmaceuticals (EGRX)

                      Eagle Pharmaceuticals (EGRX) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.

                        Zacks Equity Research

                        Top Ranked Value Stocks to Buy for January 25th

                        Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 25th:

                          Zacks Equity Research

                          5 Affordable Stocks with Impressive Returns

                          5 Affordable Stocks with Impressive Returns

                            Zacks Equity Research

                            4 Stocks Flaunting Low Price-to-Cash-Flow Ratio

                            In value investing, investors pick stocks that are cheap but fundamentally sound.

                              Zacks Equity Research

                              McKesson (MCK) to Pay $150 Million to Department of Justice

                              McKesson (MCK) has finalized to resolve U.S. Drug Enforcement Administration and Department of Justice potential federal civil and administrative claims.

                                Zacks Equity Research

                                Luxottica Group (LUX) Jumps: Stock Adds 8.2% in Session

                                Luxottica Group S.p.A. (LUX) shares rose over 8% in the last trading session.

                                  Zacks Equity Research

                                  Will Aceto (ACET) Be a Suitable Pick for Value Investors?

                                  Let's see Aceto (ACET) stock to find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.